Sanjay S. Shukla
2018
In 2018, Sanjay S. Shukla earned a total compensation of $1.4M as President and CEO at aTYR PHARMA, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $140,549 |
|---|---|
| Option Awards | $780,000 |
| Salary | $450,000 |
| Other | $9,916 |
| Total | $1,380,465 |
Shukla received $780K in option awards, accounting for 57% of the total pay in 2018.
Shukla also received $140.5K in non-equity incentive plan, $450K in salary and $9.9K in other compensation.
Rankings
In 2018, Sanjay S. Shukla's compensation ranked 7,567th out of 14,244 executives tracked by ExecPay. In other words, Shukla earned more than 46.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,567 out of 14,244 | 47th |
Division Manufacturing | 2,937 out of 5,765 | 49th |
Major group Chemicals And Allied Products | 1,102 out of 2,128 | 48th |
Industry group Drugs | 932 out of 1,817 | 49th |
Industry Biological Products, Except Diagnostic Substances | 172 out of 339 | 49th |
Source: SEC filing on March 28, 2019.
Shukla's colleagues
We found three more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2018.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019